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Abstract
Osteopontin (OPN) is a pleiotropic protein implicated in various inflammatory responses including ischemia-reperfusion (I-R)
injury. Two distinct forms of the protein have been identified: an extensively studied secreted form (sOPN) and a less-well-
known intracellular form (iOPN). Studies have shown that increased OPN expression parallels the time course of
macrophage infiltration into injured tissue, a late event in the development of cerebral infarcts. sOPN has been suggested to
promote remodeling of the extracellular matrix in the brain; the function of iOPN may be to facilitate certain signal
transduction processes. Here, we studied OPN expression in adult male Sprague-Dawley rats subjected to global forebrain I-
R injury. We found iOPN in the cytoplasm of both cortices and the hippocampus, but unexpectedly only the right cortex
exhibited a marked increase in the iOPN level after 45 min of reperfusion. Acetaminophen, a drug recently shown to
decrease apoptotic incidence, caspase-9 activation, and mitochondrial dysfunction during global I-R, significantly inhibited
the increase in iOPN protein in the right cortex, suggesting a role for iOPN in the response to I-R injury in the right cortex.
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Introduction
Osteopontin (OPN) is engaged in a variety of cellular processes
rangingfrombone resorption toimmune cellactivation,remodeling
of the extracellular matrix and inhibition of apoptosis [1,2,3]. OPN
protein levels are elevated in the days following cerebral I-R [4,5,6].
OPNexpression parallelsthe time course ofmacrophage infiltration
into the infarct [5], a late event in the development of cerebral
infarcts [7]. This suggests that the upregulation of OPN is delayed
until brain matrix remodeling is underway [5]. While delayed
expression of OPN in stroke has been reported, there are little data
on its role in cerebral injury early during cerebral I-R.
OPN can exist in two forms: secreted (sOPN) and intracellular
(iOPN). sOPN can engage various receptors (certain integrins and
CD44 variants) on the cell surface, stimulating signal transduction
pathways and cell adhesion [8,9]. Certain of these receptors are
upregulated following transient global cerebral I-R [10]. Extensive
post-translational modifications (glycosylation, phosphorylation)
can modify the interaction of OPN with other proteins. OPN can
be cleaved by thrombin, exposing a cryptic attachment motif that
is capable of engaging additional integrins [11]. iOPN, which lacks
the signal sequence that targets the protein to secretory vesicles,
possibly due to a down-stream alternative translational initiation
signal, is expressed in dendritic cells and macrophages of the
immune system [12]. In patients with advanced stages of
Alzheimer’s disease, iOPN levels are increased in pyramidal
neurons compared to normal human brain [13]; the authors
suggested that iOPN may play a role in cell cycle progression,
neuronal remyelination, and/or the formation of protein aggre-
gates in Alzheimer’s Disease. The role of iOPN in the cellular
response to stroke has not been studied.
Here, we evaluated OPN expression early after cerebral I-R in
three different areas of the brain. Next, we determined if the form of
OPN we detected in cortical brain tissue was secreted or intracellular.
Lastly, we investigated OPN expression in the presence of
acetaminophen (ACET), a drug recently shown to reduce apoptosis
and mitochondrial dysfunction in early cerebral I-R [14].
Methods
All chemicals were purchased from Sigma Aldrich, Inc. (St. Louis,
MO). The anti-OPN antibody 2A1 was developed and characterized
in our laboratory [15]. Other antibodies used were obtained from
Santa Cruz Biotech, Santa Cruz, CA unless otherwise indicated.
Animals
Rats weighing 350–400 g were obtained from Ace Animals, Inc
(Boyertown, PA) and housed in AAALAC- accredited facilities at
PLoS ONE | www.plosone.org 1 January 2011 | Volume 6 | Issue 1 | e14568Rutgers University. Four animals were used in each treatment
group described below. All animal housing conditions, surgical
protocols and postoperative care were reviewed and approved by
the Rutgers University Institutional Animal Care and Use
Committee and were carried out in accordance with the National
Institute of Health Guide for the Care and Use of Laboratory Animals (NIH
Publications No. 80-23; revised 1996).
Surgical procedure (2VO/HYP)
Transient global forebrain ischemia was induced using the two-
vessel occlusion and hypovolemic hypotension (2VO/HYP) model
[16]. The carotid arteries supply blood to a significant portion of
the brain. If carotid artery blood flow is compromised, pressure in
the vertebral arteries increases in compensation [17]. In this
model, blood flow in the vertebral arteries is reduced by
withdrawing blood from the femoral artery and then initiating
ischemia by clamping both carotid arteries. This procedure causes
significant damage to the hippocampus and cortex after 15 min of
ischemia [16,18]. Additionally, surgical manipulation is minimized
and reperfusion is readily accomplished.
Rats were anesthetized with an intraperitoneal (i.p.) injection of
ketamine:xylazine (80:12 mg/kg) with additional i.p. doses of
ketamine (80 mg/kg) administered throughout the experiment as
necessary. A ventral midline incision was made and the right
jugular vein cannulated. The carotid arteries were isolated and
marked with suture. The femoral arteries were cannulated to
monitor arterial blood pressure and to extract blood from the
animal. Lastly, the animal was intubated and connected to a
small animal respirator (Model 683, Harvard Apparatus,
Holliston, MA) to maintain physiological blood pH. The animals
maintained under these conditions for an additional 60 min are
referred to as the controls (see figure 1 below). Heparin (250 U/
kg) was administered to inhibit blood clotting and hypotension
(,55 mm Hg) was induced by withdrawing blood via the femoral
artery prior to ischemia. Withdrawn blood was placed in a
heparinized vial and maintained at 37uC. Ischemia was initiated
by clamping the carotid arteries for 15 min. Reperfusion was
initiated by unclamping the carotid arteries and returning
withdrawn blood to the animal. ACET was administered via
the jugular vein. Body temperature was maintained within
physiological range. The animal was sacrificed after 45 min of
reperfusion.
Treatment protocols (Figure 1)
Controls. Rats were instrumented as described above but
were not subjected to I-R. They were maintained under steady-
state conditions for 75 min.
Protocol 1 Vehicle (P1VEH). Rats were instrumented and
subjected to hypotension, carotid artery occlusion and 60 min of
I-R. Vehicle (0.2–0.3 mL of 0.15 M saline) was administered
immediately prior to ischemia.
Protocol 1 ACET (P1ACET). Rats were instrumented as
above and subjected to hypotension, carotid artery occlusion and
I-R. A 15 mg/kg dose of ACET (0.125 M in 0.15 M saline, 0.2–
0.3 mL) was administered immediately prior to ischemia.
Protocol 2 Vehicle (P2VEH). Rats were instrumented as
above and subjected to hypotension, carotid artery occlusion and
I-R. A 0.2–0.3 mL dose of 0.15 M saline was administered
immediately prior to ischemia and again immediately prior to
reperfusion.Thedoseswereadministeredseparatelytoavoidalarge
infusion volume, which is known to cause vascular damage [19].
Protocol 2 ACET (P2ACET). Rats were instrumented as
above and subjected to hypotension, carotid artery occlusion and
I-R. A 15 mg/kg dose of ACET (0.125 M in 0.15 M saline, 0.2–
0.3 mL) was administered immediately prior to ischemia and
again immediately prior to reperfusion.
At the end of reperfusion, animals from all groups were
sacrificed by transcardial perfusion of ice-cold PBS until the blood
was completely flushed out. For immunocytochemical analysis,
animals were also transcardially perfused with 4% paraformalde-
hyde in PBS (PFA). In P1VEH and P1ACET rats, brains were
extracted and the left and right cerebral cortices as well as the
hippocampus were evaluated. In P2VEH and P2ACET rats, only
the right cortex was evaluated. Tissues used for cytosolic/
mitochondrial fractionation and Western blotting were obtained
from animals transcardially perfused with ice-cold PBS.
Evaluation of OPN expression in brain tissue
The left and right cortical hemispheres from control, P1VEH
and P1ACET rats were placed in 4% PFA overnight at 4uC.
Tissue was cryoprotected by consecutive 8-h incubations in 10, 20
and 30% sucrose respectively at 4uC. Tissue was prepared for
cryosectioning by incubation in 30% sucrose/50% OCT (v/v) for
1 h followed by incubation in 100% OCT at 4uC for 1 h. The
tissue was then embedded in OCT over dry ice and 10 mm-thick
Figure 1. Schematic of experimental timeline. Rats were surgically instrumented and maintained under steady-state conditions for 15 min prior
to initiating I-R. At that point, animals were rendered hypotensive (mean arterial pressure ,55 mm Hg) by withdrawing 5 mL of blood, and the
carotid arteries were clamped to induce ischemia. Reperfusion was begun by unclamping of the carotid arteries and returning the withdrawn blood
to the animal. Control animals were surgically instrumented but were not subject to hypotension or I-R. In Protocol 1, acetaminophen (ACET) (15 mg/
kg) was only administered prior to ischemia, whereas in Protocol 2, ACET (15 mg/kg) was administered prior to ischemia and again immediately
before the onset of reperfusion.
doi:10.1371/journal.pone.0014568.g001
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St. Gallen, Switzerland). Slides were stored at 270uC prior to
analysis. Sixteen slides (four slides per animal) were analyzed from
each treatment group.
For immunocytochemical analysis, sections were first washed in
PBS.Endogenoushydrogenperoxidaseswerequenchedusing 0.3%
H2O2 inPBS for30 min. Sectionswerethen blocked in1%BSAfor
1 h followed by incubation with 2A1 (0.02 mg/mL) overnight at 4uC
in a humidified chamber. The 2A1 antibody used in this study was
generated in our laboratory; it binds to an epitope [(A/V)IPVAQ]
centrally located in the C-terminal thrombin cleavage fragment
about 50 amino acids downstream of the RGD integrin-binding site
(humans, mice, rats, rabbits; not cows, pigs or chickens). The
epitope is not subject to post-translational modifications that can
interfere with antibody-epitope recognition [15]. A few sections
were used as negative controls, where the primary antibody was
omitted. Slides were then incubated with secondary HRP-
conjugated goat anti-mouse antibody (1:50, BioRad, Hercules,
CA) for 1 h. Immunostaining was developed by the peroxidase-
antiperoxidase procedure using 3-39-diaminobenzidine (Dako,
Glostrup, Denmark) as the cosubstrate. Sections were counter-
stained with hematoxylin before mounting. Four 20X fields were
chosen to best reflect the overall immunostaining of the cerebral
cortex of each slide. Cytoplasmic expression of iOPN was
determined as described [13]. OPN abundance was quantified
using Adobe Photoshop Software [20]. Four 20X fields were
digitally acquired from each cortical tissue section and opened using
Photoshop software. The mean values were normalized to
background values and compared between the control, P1VEH
and P1ACET groups. Staining intensities are expressed as a
percentage of control values.
Evaluation of injury from ischemia-reperfusion
A key characteristic of damaged neurons is the presence of
pyknotic (condensed) nuclei. Morphological changes in the CA1
region of the hippocampus were determined as described [21].
Tissue sections from the left and right hippocampi of control and
P1VEH brains were stained with hematoxylin and eosin. Neurons
exhibiting pyknotic nuclei were counted (magnification, 20X).
Pyknotic neuronal cell counts were compared between control and
P1VEH brains for left and right hippocampi respectively.
Cytosolic/mitochondrial fractionation
Tissue samples were separated into cytosolic and mitochondrial
fractions as previously described [14]. Each dissected brain region
was placed in ice-cold homogenization buffer (210 mM mannitol,
7 mM sucrose, and 5 mM 4-morpholinopropanesulfonic acid,
pH 7.4, 25uC, with 1 mM PMSF and protease inhibitor cocktail)
and homogenized with 10–15 strokes using a Dounce Homoge-
nizer (Fisher Scientific, Waltham, MA). Samples were centrifuged
at 4000 g for 10 min at 4uC to remove intact cells and cellular
debris. The supernatant was transferred to a separate tube and
centrifuged again at 7000 g for 10 min at 4uC. The supernatant
(the cytosolic fraction) was carefully removed from the pellet (the
mitochondrial fraction).
Detection of OPN and cytochrome c content by Western
Blotting
The protein concentration in each sample was determined using
the Bradford method. Cytosolic and mitochondrial proteins (10 mg)
were resolved on a 12% SDS-polyacrylamide gel at 100 V for 2 h.
Proteins were then transferred to an Immobilon-P membrane
(Millipore, Billerica, MA) and blocked with 2% BSA followed by
incubationwithprimary mouse monoclonal antibody (2A1, 0.5 ng/
mL) overnight at 4uC. Membranes were washed with TBS-T buffer
and then incubated with HRP-conjugated goat anti-mouse
secondary antibody (1:6000, Bio-Rad, Hercules, CA) for 45 min.
Blots were developed using the ECL
+ reagent (Amersham
Biosciences, Piscataway, NJ). Film was analyzed using NIH-
developed software (Image J, http://rsbweb.nih.gov/ij/). Mem-
branes were stripped using mild stripping buffer (0.2 mM glycine,
0.003 mM SDS, 0.01% Tween-20, pH 2.2) and blocked with 2%
BSA for 2 h at room temperature. Then, membranes were
incubated with polyclonal rabbit anti b-tubulin antibody (1:1000)
and secondary HRP-conjugated goat anti-rabbit antibody (1:4000,
Bio-Rad, Hercules, CA). Blots were developed and analyzed as
above; protein molecular weight markers were the Benchmark Pre-
stained Protein Ladder (Invitrogen, Carlsbad, CA). The level of
OPN in each cytosolic sample was expressed as a ratio to b-tubulin.
Each experiment was performed four times with consistent results.
Mitochondrial samples were probed with anti-cytochrome c
antibody to determine the differences in cytochrome c content
between groups. Membranes were stripped and incubated with a
primary polyclonal goat antibody against mitochondrial-specific,
voltage-dependent anion channel protein (VDAC, 1:1000) and
then incubated with secondary donkey HRP-conjugated anti-goat
antibody (1:6000). Although the mitochondrial number of each
sample was not determined, equal amounts of mitochondrial
protein from each sample were analyzed to ensure objective
comparison between treatment groups. Blots were obtained as
described above. All experiments were performed in duplicate,
yielding comparable results.
Statistical analysis
Data are presented as means 6 SD. Statistical differences
between two groups were assessed using two-tailed, unpaired
Student’s t tests. Differences among three groups were analyzed
using one-way analysis of variance (ANOVA) followed by Tukey’s
post-test for means comparison (GraphPad Software, La Jolla,
CA). Significance was accepted at P,0.05.
Results
iOPN expression in the cytoplasm of the cortex:
enhanced by ischemia-reperfusion only in the right
cortex
We employed immunocytochemistry on tissue sections obtained
from the left and right hemispheres to investigate the presence of
OPN and its response to I-R. We observed a staining pattern in
brain tissue (Figure 2A and insert) consistent with a cytoplasmic
localization iOPN. The inserts show more magnified views,
confirming the presence of iOPN in the cytosol. Because the
brain was flushed with PBS prior to preparation for immunocy-
tochemistry, it would be essentially free of blood cells or plasma
that might contain sOPN. Interestingly, iOPN protein was
uniquely elevated in the right cortex of the P1VEH animals
following I-R injury, and ACET inhibited that increase (Figure 2A,
B). Please note that VEH designates animals that received only the
vehicle in which the acetaminophen is dissolved.
Response to I-R injury in the right and left hippocampi
Analysis of tissue from the CA1 regions of the hippocampi from
the left and right hemispheres (Figure 3A) revealed a significant
increase in pyknotic neurons in the P1VEH group compared to
the control, for both left and right hippocampi, indicating that
there was more neuronal damage in the P1VEH group than in the
instrumented control rats. The nuclei in hippocampal sections
Regulation of iOPN during I-R
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than the condensed nuclei in the sections from vehicle animals.
There were no significant differences in pyknotic neuronal counts
between left and right hippocampi in the P1VEH group,
suggesting that the extent of neuronal damage in the P1VEH
group was similar between left and right hippocampi (Figure 3).
OPN expression in the hippocampus
The hippocampus is one of the regions in the brain severely
affected by the 2VO/HYP procedure used in this study [16], thus
we chose to examine this region. Western blot analysis of the
cytosolic fractions of hippocampus tissue revealed a 30-kDa species
(Figure 4A) as shown by others [4]; OPN species in the 55–70-kDa
range (full-length and post-translationally modified) were not
detected.
iOPN is highly expressed in the right cortex during early
I-R: Western blot analysis
Cerebral lateralization (biochemical, physiological, functional
differences between right and left halves of the brain) is a poorly
understood phenomenon, which we discuss further below. These
differences can cause the two halves of the brain to respond
differently to the same stimulus, I-R injury for example. In the
Western blot analysis of cytosolic fractions from the left and
right cortex of control, P1VEH and P1ACET rats revealed a 30-
kDa band (Figure 4A). OPN species in the 55–70-kDa region
were again not detected. The right cortex of group P1VEH
exhibited a marked increase in iOPN expression compared to
the other groups (Figure 4B), consistent with the results
presented above in figure 2B. To confirm our results with
protocol 1, we assayed iOPN expression in the right cortex of
Figure 2. Immunocytochemical analysis of iOPN expression. A: Representative sections exhibiting iOPN expression from the left (top) and
right (bottom) cortex in control, P1VEH and P1ACET animals. We detected iOPN in the cytoplasm (labeled C, insets). A negative staining control from
the right cortex is shown for comparison. In the right cortex, higher iOPN expression was evident in vehicle rats compared to control and ACET
(15 mg/kg)-treated rats. B. The intensity of staining was quantified as described in Methods. The right cortex of vehicle rats shows a significant
increase in iOPN expression compared to ACET (15 mg/kg)-treated rats. *P,0.05 determined using one-way ANOVA followed by Tukey’s post test.
Error bars indicate S.D. Scale bars =25 mm.
doi:10.1371/journal.pone.0014568.g002
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pattern where iOPN expression was markedly increased in
P2VEH rats compared to control and P2ACET animals
(Figure 4C).
ACET prevents mitochondrial release of cytochrome c
We previously showed that ACET treatment (15 mg/kg)
mitigated the extent of mitochondrial disruption resulting from
I-R injury similar to that induced here [14]. Cytochrome c, which
is normally sequestered in the mitochondria, triggers apoptosis
when released into the cytosol [22]. We employed Western
blotting to determine whether the ACET treatment in Protocol 2
was effective in preventing release of cytochrome c. Our data
(Figure 5) show that mitochondrial cytochrome c content was
maintained with ACET treatment, whereas P2VEH rats exhibited
a marked decrease in cytochrome c content.
Discussion
iOPN expression in the brain
Here, we report for the first time that iOPN protein levels are
specifically increased in the right cortex early after transient global
cerebral ischemia/reperfusion (15/45 min) in rats, suggesting a
role for the protein as a responder to stroke-induced cell damage.
Figure 3. Neuronal damage does not differ between left and right hemispheres in the CA1 region of the hippocampus. A.
Representative hematoxylin and eosin-stained tissue sections show pyknotic neurons (black arrowheads) in the CA1 regions of the hippocampi
obtained from controls and P1VEH rats. Sections of the CA1 regions of the left and right hippocampi regions from control rats show an abundance of
normal neurons (white arrowheads). B. Quantitative analysis reveals a significantly higher number of pyknotic neurons in vehicle rats compared to
corresponding control animals. There are no differences in pyknotic neuronal cell count between left and right hippocampi regions of P1VEH rats.
Scale bars =10 mm. Error bars indicate S.D. *P,0.05 determined using Student’s t test.
doi:10.1371/journal.pone.0014568.g003
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evident in the right cortex but not the hippocampus (right or left)
or left cortex. Both common carotid arteries were occluded in the
2VO/HYP model [16] used in this study; thus experimental
manipulation is unlikely to contribute to the differences in cortical
expression of iOPN.
Little is known about the expression patterns and role of iOPN
early during cerebral I-R. Changes in gene expression can occur as
early as 15 min following a cerebral insult [23] and protein
synthesis is significantly affected as well [24]. Cerebral ischemia
can initiate the transcription of immediate early genes – some
required for cellular recovery– that code for transcription factors
[25], while inhibiting translation [22]. Increased transcription,
translation, or stability of the mRNA and/or protein could
account for the increased abundance of iOPN after I-R injury.
Differences in spatio-temporal up-regulation of OPN mRNA have
been described previously in the hippocampus and the striatum
following global forebrain ischemia [26].
Figure 4. iOPN expression in the hippocampus, left cortex and right cortex. A. Representative Western blots of cytosolic fractions from the
hippocampus, left cortex and right cortex of control, P1VEH, and P1ACET rats reveal a ,30 kDa OPN species; species of lower mobility were not
detected. Control animals were instrumented, but not subject to I-R. B. Quantitative densitometric analysis of iOPN bands normalized to their
corresponding b-tubulin bands confirmed a significant increase of iOPN in vehicle rats in the right cortex. C. Representative Western blots of cytosolic
fractions from the right cortex of control, P2VEH and P2ACET rats. D. Quantitative densitometric analysis of iOPN bands normalized to their
corresponding b-tubulin bands confirmed a significant increase in iOPN expression in P2VEH rats that is reduced by about 50% in the P2ACET rats.
Error bars indicate S.D. *P,0.05 determined using one-way ANOVA followed by Tukey’s post test.
doi:10.1371/journal.pone.0014568.g004
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ACET (15 mg/kg) reduced cerebral injury, apoptosis-mediated
DNA fragmentation, and mitochondrial release of cytochrome c
following early cerebral I-R. Here, we administered an additional
dose (15 mg/kg) at the end of ischemia and found a reduction in
iOPN expression similar to that noted with a single dose. We
found that the administration of two doses had a similar action to
the single dose, causing a similar reduction in mitochondrial
release of –cytochrome c (Figure 5).
Cerebral lateralization: the underlying biochemistry
Gene expression in the left and right cortices varies during
development [27] and in response to certain physiological or
pathological inputs [28]. Clinical studies have shown that the
cortical location of the lesion (left vs. right) in stroke patients leads
to varied outcomes regarding speech, motor and memory
rehabilitation [29,30]. In our study, no significant differences in
iOPN protein levels were found between the left and right cortical
tissue obtained from control animals. Unexpectedly however, in
response to I-R injury, the iOPN protein level was significantly
and rapidly enhanced only in the right cortex.
There are several studies demonstrating differences between the
two hemispheres in various settings including stroke. Studies by
Robinson [31,32] found spontaneous hyperactivity and a decrease
in catecholamine concentrations in rats following right middle
cerebral artery ligation, but not with left middle cerebral artery
ligation. In these studies, right and left hemispheric infarctions
were comparable in their locations and extent of tissue damage.
Similarly, rat spinal fluid monoamine metabolite concentrations
were reduced only on the right side compared to controls, and not
on the left side [33]. The right-specific laterality has also been
demonstrated in rat studies of stress-related processes where
medial prefrontal cortex output neurons demonstrated an intrinsic
right brain specialization in both neuroendocrine and autonomic
activation [34]. These differences have been proposed to have a
biochemical basis [35].
Figure 5. Acetaminophen (ACET) maintains mitochondrial cytochrome c content in rats subjected to Protocol 2. A: Representative
Western blots of the mitochondrial fractions from the right cortex of control, P2VEH, and P2ACET rats. B: Quantitative densitometric analysis of
cytochrome c bands normalized to their corresponding VDAC bands confirms a significant decrease in cytochrome c content in vehicle rats. Error bars
indicate S.D. *P,0.001 determined using Student’s t test.
doi:10.1371/journal.pone.0014568.g005
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between the right and left hemispheres in models of global
ischemia, there is evidence for this possibility. Functional
asymmetries have been reported in the rat brain over several
decades [36]. Major laterality has been noted in the expression of
protein molecules between the right and the left hippocampi in
rats [37]. Thus there is precedent for the right and the left
hemispheres responding differently to a cerebral insult and that the
right cortex could be more susceptible to injury from I-R when
compared to the left cortex. In rat hippocampi, laterality has been
shown in the expression of the anti-inflammatory protein HSP70,
with Samara et al. [37] demonstrating that the left side expresses
nearly 3 times as much HSP70 as the right side under normal
conditions. In our study, although examination of the pyknotic
nuclei (indication of cell damage) showed no differences between
the left and right CA1 regions of the hippocampi, it is possible that
a similar laterality in expression of HSP70 might explain the
differences in OPN expression between the left and right cortices
following cerebral I-R.
Nitric oxide, a product of nitric oxide synthase activation, is an
important mediator of ischemic brain injury [38]. There are three
isoforms of nitric oxide synthase, namely neuronal nitric oxide
synthase (nNOS), endothelial nitric oxide synthase (eNOS) and
inducible nitric oxide synthase (iNOS). All three forms are
upregulated following cerebral I-R [39]. In particular, nNOS
and iNOS upregulation have been reported to occur within
15 min of cerebral I-R [40]. Several studies have revealed that
OPN inhibits iNOS expression in various contexts [41,42,43]. It is
conceivable that the right cortex is more sensitive to I-R, inducing
greater iNOS expression as a response to the insult, where an
upregulation in iOPN is a preventative measure to curtail the
damaging effects of NO.
Cerebral insults initiate changes in expression of many proteins,
including interleukin-1 beta (IL-1b), tumor necrosis factor alpha
(TNFa), and the 70-kDa heat shock protein (HSP70). All these
proteins have been shown to be expressed early after cerebral I-R:
IL-1b within 15–30 minutes [44], TNFa within 1 hour [45], and
HSP70 also within 1 hour [46]. IL-1b and TNF-a regulate
nuclear factor interleukin-6 (NF-IL6), which stimulates OPN gene
transcription [47]. Another potential explanation for the observed
cortical differences in iOPN expression lies in the varying
abundance of existing proteins in each cortex. Here we showed
that iOPN protein is rapidly upregulated in the right cortex. No
significant change in iOPN abundance was observed in the left
cortex. While the reason for this is not known, it is likely the result
of the differential expression of other genes in the two cortices of
the rat brain.
We are not aware of any studies showing hemispheric
differences in cerebral blood flow resulting from the 2VO/HYP
procedure or differences in the internal diameters of cerebral
vasculature between the two hemispheres. Thus, our results are
unlikely to be explained by bilateral differences in cerebral
vascular architecture, autoregulatory capacities, or metabolic/
neurogenic vasomotor specializations. We suggest instead that the
hemispheric differences in iOPN expression detected in our study
of I-R injury are related to biochemical differences, not to
differences in lesion size or location within the hemispheres.
Although iOPN is thought, in part at least, to serve an adaptor (or
scaffold) function facilitating signal transduction pathways, nothing
is known about how its expression is controlled [48]. While the
significance of our findings has yet to be explored, they highlight
the emerging importance of investigating differences in the control
of gene expression in the left and right hemispheres of the brain.
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